H. Lee Moffitt Cancer Center and Research Institute: Pancreatic Neoplasms trials

The registry lists 27 Pancreatic Neoplasms studies with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor. 2 are open to participants now and 3 have results posted.

Early Phase 1 2Phase 1 7Phase 2 4No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A First-in-Human Study of FID-022 in Solid Tumor PatientsRecruitingNCT07249775
• Remote Exercise and Nutritional Prehabilitation for Pancreatic CancerRecruitingNCT06423963Not applicable
• FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine CarcinomasTerminatedNCT03042780Phase 2Results posted
• GTX-RT in Borderline Resectable Pancreatic CancerTerminatedNCT01754623Phase 2Results posted
• Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic RadiosurgeryTerminatedNCT00833859Phase 2Results posted
• Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception CenterActive, not recruitingNCT06712797Not applicable
• Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)Active, not recruitingNCT06519097Phase 2
• Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic CancerCompletedNCT06378047Phase 1
• Cancer Coaching and Remote Education for Self-Empowerment (CARES) StudyCompletedNCT06323291Early Phase 1
• The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment ResponseCompletedNCT06050395Not applicable
• Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)Active, not recruitingNCT06001268Not applicable
• Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority PopulationsActive, not recruitingNCT05687188
• Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer PatientsCompletedNCT05675059Not applicable
• Early Supportive Care and Nutritional Support in Adults With Pancreatic CancerCompletedNCT05438927Not applicable
• Wet Heparinized Suction for Abdominal CancerWithdrawnNCT05041335Not applicable
• Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the PancreasActive, not recruitingNCT04275557
• Florida Pancreas Collaborative Next Generation BiobankActive, not recruitingNCT03851133
• Total Tumor Mapping (TTM) for Resectable Pancreatic CancerWithdrawnNCT03718650Early Phase 1
• BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic CancerCompletedNCT02155088Phase 1
• Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic CancerCompletedNCT02138383Phase 1
• Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic CancerCompletedNCT01662609
• Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic TumorsTerminatedNCT01455311
• Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic CancerWithdrawnNCT01434550Not applicable
• SOM 230 and Gemcitabine in Advanced Pancreatic CancerCompletedNCT01385956Phase 1
• Gem-TABS in Unresectable Pancreatic CarcinomaCompletedNCT01198821Phase 1
• Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine NeoplasiaCompletedNCT00985777Phase 1
• A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic CancerCompletedNCT00480584Phase 1